JANSSEN PHARMACEUTICALS, INC.
🇺🇸United States
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
24
FDA:18
NMPA:5
SFDA:1
Drug Approvals
Methylphenidate Hydrochloride Extended-Release Tablets
- Product Name
- 专注达
- Approval Number
- 国药准字HJ20225002
- Approval Date
- Jun 21, 2022
NMPA
Methylphenidate Hydrochloride Prolonged-Release Tablets
- Product Name
- 专注达
- Approval Number
- 国药准字HJ20170263
- Approval Date
- Jun 9, 2022
NMPA
Methylphenidate Hydrochloride Prolonged-Release Tablets
- Product Name
- 专注达
- Approval Number
- 国药准字HJ20170264
- Approval Date
- Jun 9, 2022
NMPA
Methylphenidate Hydrochloride Prolonged-Release Tablets
- Product Name
- 专注达
- Approval Number
- 国药准字HJ20170262
- Approval Date
- Jun 9, 2022
NMPA
Methylphenidate Hydrochloride Prolonged-Release Tablets
- Product Name
- 专注达
- Approval Number
- 国药准字HJ20170265
- Approval Date
- Jun 9, 2022
NMPA
Clinical Trials
No trials found
News
No news found